Diagnostic Value of Dynamic Contrast-Enhanced MRI in Identifying Diabetic Foot Osteomyelitis Requiring Aggressive Treatment
DOI:
https://doi.org/10.18502/ijdo.v18i4.23241Keywords:
Diabetic foot ulcer, Osteomyelitis; DCE-MRI, Time–signal intensity curveAbstract
Objective: Early identification of diabetic foot osteomyelitis (DFO) patients who will fail antibiotic therapy is critical for timely escalation to surgical or revascularization treatment. Dynamic contrast-enhanced MRI (DCE-MRI) quantifies tissue perfusion through time–signal intensity curves (TICs) and may provide a prognostic marker of treatment outcome beyond conventional morphological MRI.
Materials and Methods: In this prospective study, 21 patients with type 2 diabetes and clinically suspected foot osteomyelitis referred to the Yazd Diabetes Research Center underwent conventional MRI and DCE-MRI at Shahid Sadoughi Hospital. A 13-series dynamic acquisition was obtained over 270 seconds after intravenous gadolinium, and TICs were classified as F (rapid early enhancement), S (slow early enhancement), or O (weak or absent enhancement). Patients then received approximately six weeks of standard antibiotic therapy and were classified as treated (n= 8, 38%) or untreated/failed (n= 13, 62%) by clinical criteria.
Results: All 8 treated patients (100%) showed an F-type curve, whereas 10 of 13 untreated patients (77%) showed S- or O-type curves; the association between curve type and outcome was significant (P= 0.003). Treated patients had significantly higher maximum signal intensity (306.00 (± 28.55) vs. 157.38 (± 90.25), P= 0.001), higher average signal intensity (224.88 (± 28.78) vs. 109.31 (± 70.27), P< 0.001), and shorter time to bolus peak (38.13 (± 2.85) vs. 63.10 (± 13.90) seconds, P< 0.001).
Conclusion: F-type TIC and higher perfusion parameters on DCE-MRI were strongly associated with successful antibiotic therapy, whereas S- and O-type curves predicted treatment failure.